// App-Quantinova.ai

TCT-36 : The Impact of Guideline-Directed Medical Therapy after Revascularization in Patients With Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

Researchers

Presenter

  • R. Jay Widmer

Principal Investigators

  • Bernard Gersh

  • Patrick Serruys

  • John Puskas

  • Ori Ben-Yehuda

  • David Taggart

  • Marie-Claude Morice

  • Nicholas Lembo

  • William Brown

  • Adrian Banning

  • Yiran Zhang

  • Ovidiu Dressler

  • A. Pieter Kappetein

  • Joseph Sabik

  • Gregg Stone

Medical Centers

  • Piedmont Heart Institute CardioThoracic Surgeons, Atlanta, Georgia, United States

  • Mount Sinai, NY, New York, New York, United States

  • Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York, United States

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • CERC, Massy, France

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • Imperial College, London, United Kingdom

  • Mayo Clinic, Rochester, Minnesota, United States

  • John Radcliffe Hospital, Oxford, United Kingdom.

Locations

  • United States

  • United Kingdom

  • Netherlands

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Cardiovascular (CVS)

Disease

  • Left main disease

  • Congestive heart failure

  • Hypertension

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Adenosine

  • Adenosine Intravenous

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved